Stock listing
Catalyst Pharmaceuticals, Inc.
Selected listing: CN2 · BX · CHF · CH
Catalyst Pharmaceuticals, Inc. (BX Swiss: CN2), Health Technology. Latest release Jun 30, 2026: Vamorolone Demonstrates On-Target Glucocorticoid Activity…
- Ticker
- BX Swiss: CN2
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- BX Swiss
- Currency
- CHF
About Catalyst Pharmaceuticals, Inc.
The company focuses on developing and commercializing innovative therapies for rare diseases. Catalyst Pharmaceuticals is committed to improving the lives of patients through its specialized treatments.
Latest news from Catalyst Pharmaceuticals, Inc.
Vamorolone Demonstrates On-Target Glucocorticoid Activity Without the Immunosuppression Characteristic of Traditional Corticosteroids at Clinical Doses
June 30, 2026
Catalyst Pharmaceuticals Reports First Quarter 2026 Financial Results
May 11, 2026
Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease
May 7, 2026
Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Hetero Labs Ltd.
May 7, 2026
Catalyst Pharmaceuticals to Report First Quarter 2026 Financial Results on May 11, 2026
April 28, 2026
Events
Research Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals, Inc. company profile
View the public company page for Catalyst Pharmaceuticals, Inc. on 6ix.
Catalyst Pharmaceuticals, Inc. news
Read company news and market updates connected to Catalyst Pharmaceuticals, Inc..
Catalyst Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Catalyst Pharmaceuticals, Inc..
Alternate listings
CPRX:NASDAQ
US · USD
Alternate listing for Catalyst Pharmaceuticals, Inc.; the primary context on this page is CN2:BX.
CN2:GETTEX
DE · EUR
Alternate listing for Catalyst Pharmaceuticals, Inc.; the primary context on this page is CN2:BX.
A0LCUL:LSX
DE · EUR
Alternate listing for Catalyst Pharmaceuticals, Inc.; the primary context on this page is CN2:BX.
CPRX:BOATS
US · USD
Alternate listing for Catalyst Pharmaceuticals, Inc.; the primary context on this page is CN2:BX.
CN2:TRADEGATE
DE · EUR
Alternate listing for Catalyst Pharmaceuticals, Inc.; the primary context on this page is CN2:BX.
CN2:FWB
DE · EUR
Alternate listing for Catalyst Pharmaceuticals, Inc.; the primary context on this page is CN2:BX.
A0LCUL:LS
DE · EUR
Alternate listing for Catalyst Pharmaceuticals, Inc.; the primary context on this page is CN2:BX.
CN2:SWB
DE · EUR
Alternate listing for Catalyst Pharmaceuticals, Inc.; the primary context on this page is CN2:BX.
CN2:DUS
DE · EUR
Alternate listing for Catalyst Pharmaceuticals, Inc.; the primary context on this page is CN2:BX.
CN2:HAM
DE · EUR
Alternate listing for Catalyst Pharmaceuticals, Inc.; the primary context on this page is CN2:BX.
CN2:MUN
DE · EUR
Alternate listing for Catalyst Pharmaceuticals, Inc.; the primary context on this page is CN2:BX.